Deal will boost company's pharmaceutical commercialization influence
Envision Pharma Group, a UK-based scientific communications company, has acquired Two Labs, a strategic consulting and commercialization provider with a footprint in the US pharma domestic market. Two Labs is known for helping pharma companies develop and execute customized launch strategies for products, a process that may include selecting a third-party logistics provider (3PL).
Howard Miller, CEO, Two Labs, noted, “We are delighted to be joining the Envision family and taking Two Labs to the next logical step in its successful journey to date. With Envision’s global footprint and Two Labs’ market-leading US footprint, we have a unique opportunity to enrich our client partnerships with more connected services across the launch continuum.”
He pointed as well to a “compelling” cultural fit between the two organizations.
Envision’s acquisition of Two Labs follows the recent announcement of GHO Capital’s increased investment in the company and management support for its continued expansion. Since its inception in 2001, Envision has produced solid organic growth, while also providing medical affairs strategy, medical communications, and its iEnvision technology.